1. Home
  2. TASK vs IRWD Comparison

TASK vs IRWD Comparison

Compare TASK & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TaskUs Inc.

TASK

TaskUs Inc.

HOLD

Current Price

$7.90

Market Cap

598.9M

Sector

Technology

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.27

Market Cap

713.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TASK
IRWD
Founded
2008
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
598.9M
713.8M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
TASK
IRWD
Price
$7.90
$4.27
Analyst Decision
Hold
Buy
Analyst Count
5
3
Target Price
$14.70
$7.67
AVG Volume (30 Days)
627.1K
1.7M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
120.00
1400.00
EPS
0.50
0.55
Revenue
N/A
$298,276,000.00
Revenue This Year
$5.95
$57.95
Revenue Next Year
$6.46
$4.39
P/E Ratio
$16.26
$7.87
Revenue Growth
N/A
8.88
52 Week Low
$4.47
$1.05
52 Week High
$18.39
$5.78

Technical Indicators

Market Signals
Indicator
TASK
IRWD
Relative Strength Index (RSI) 59.56 53.43
Support Level $6.30 $3.85
Resistance Level $8.18 $4.53
Average True Range (ATR) 0.40 0.18
MACD -0.03 -0.00
Stochastic Oscillator 77.36 66.32

Price Performance

Historical Comparison
TASK
IRWD

About TASK TaskUs Inc.

TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: